Investing & trading with exchange-traded funds (ETFs) and closed-end funds (CEFs). Strategies & analysis but no buy or sell recommendations.

Visit SeekingAlpha ETFs

Abbott Laboratories: The Choice Within Big Pharma

Posted on July 29, 2008

So Big Pharma is hurting? Well, Standard & Poor s does estimate that patent expiration losses in 2008 will exceed $20 billion. I cannot even remember the last time Merck (MRK) got something approved or did not report poor results from a clinical trial. Does Pfizer (PFE) have a strategy going forward to make up for the loss of Lipitor?The outlook for Big Pharma is very disheartening through 2012. Are there any companies that have slipped through the cracks and emerged as a great Large Cap Pharma player? I can say confidently that Abbott Laboratories (ABT) [56.21, 0.00 (0.00%)] is a fundamenta...

Original article link


clinical trial , pharma